Although NGAL has been in focus for many years as a marker of AKI, recent data suggests that its ability to distinguish between inflammatory activation and AKI is poor [8], and in many instances, plasma NGAL levels are to a greater extent related to the inflammatory response rather than to AKI. Here, LCN2 is linked to acute kidney injury.